Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Multiple-Dose,Double-Blind,Crossover Trial to Assess the Systemic Exposure of Fluticasone Propionate (FP)/Formoterol Fumarate (FF) Fixed-Dose Combination in Subjects With Chronic Obstructive Pulmonary Disease (COPD)

NCT00774761 is registered in ClinicalTrials.gov with Dey as lead sponsor.

NCT NCT00774761
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00774761 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Multiple-Dose,Double-Blind,Crossover Trial to Assess the Systemic Exposure of Fluticasone Propionate (FP)/Formoterol Fumarate (FF) Fixed-Dose Combination in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
Lead sponsor
Dey
Phase
Phase 2
Overall status
Completed
Start date
November 30, 2008
Completion date
May 31, 2009
Enrollment
97 (actual)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

chronic obstructive pulmonary disease